The Affordable Care Act was sold, defended, attacked, repaired, sued, celebrated, and yelled about at Thanksgiving dinners as a serious attempt to make American health insurance more humane. Its big promises were simple enough for a bumper sticker: cover people with preexisting conditions, stop junk insurance from pretending to be real coverage, expand access, and make essential health benefits less optional than a dentist’s lecture about flossing.
Then, tucked into the policy machinery, came a quieter but highly controversial provision: Section 2706, often called the provider nondiscrimination rule. Its basic language says health plans should not discriminate against any health care provider acting within the scope of that provider’s state license or certification. On paper, that sounds fair. Nobody wants qualified clinicians blocked merely because they have a different credential.
But here is where the policy bicycle hits a pothole. Because many states license complementary and alternative medicine providers, including chiropractors, acupuncturists, naturopaths, and other non-MD practitioners, an expansive reading of Section 2706 can pressure insurers to treat licensed CAM providers as if licensure alone should unlock coverage. That is the heart of what critics call “Harkin’s folly,” named after former Senator Tom Harkin, a long-time champion of alternative medicine and a key supporter of CAM’s federal policy rise.
The problem is not that every massage, acupuncture session, or chiropractic visit is automatically useless. Health care is not that tidy. The problem is that the ACA was supposed to make insurance more evidence-based and more financially sustainable, while forced or quasi-forced CAM coverage risks pushing plans in the opposite direction: toward benefit design shaped by professional lobbying, state licensing politics, and consumer demand rather than strong clinical evidence.
What Is CAM, and Why Does It Matter in Health Insurance?
CAM stands for complementary and alternative medicine. “Complementary” usually means a non-mainstream approach used alongside conventional care. “Alternative” means a non-mainstream approach used instead of conventional care. That difference matters. Green tea after chemotherapy is one thing. Green tea instead of chemotherapy is a medical horror movie with no popcorn.
CAM includes a wide range of practices: acupuncture, chiropractic manipulation, naturopathy, homeopathy, herbal supplements, massage therapy, reiki, energy healing, detox programs, and various mind-body interventions. Some of these practices have limited evidence for specific uses. Others have weak evidence, implausible mechanisms, or claims that sprint far beyond the data like a wellness influencer late for a podcast.
Americans use complementary health approaches frequently, especially for pain, stress, sleep, and general wellness. That popularity creates political pressure. If millions of people pay out of pocket for acupuncture or chiropractic care, professional associations naturally argue that insurance should cover it. Consumers may agree, especially when premiums already feel like a second mortgage with worse customer service.
Yet health insurance is not simply a wish list. Insurance works by pooling risk and paying for necessary care. When a plan must cover more services, someone pays: the enrollee through premiums, the patient through cost sharing, the employer through benefit costs, or taxpayers through subsidies. There is no magic drawer labeled “free wellness money.”
The ACA’s Real Mission: Access, Essential Benefits, and Affordability
The ACA’s core architecture rests on a tradeoff. Insurers can no longer reject people because they are sick, charge them more because of health status, or sell flimsy coverage that evaporates during a medical crisis. In exchange, the law tries to bring healthier people into the market, standardize benefits, provide subsidies, and manage risk across a broad pool.
The law also created essential health benefits for individual and small-group plans. These include categories such as emergency services, hospitalization, maternity and newborn care, prescription drugs, mental health and substance use disorder services, preventive care, laboratory services, pediatric care, and rehabilitative services. These are not luxury extras. They are the load-bearing beams of serious coverage.
When policymakers expand mandatory coverage beyond evidence-based medical necessities, the ACA’s affordability promise gets weaker. Every additional benefit may sound compassionate in isolation. But stack enough marginal benefits together and the premium begins lifting weights at the gym. For people hovering just above subsidy eligibility, even modest premium increases can matter.
Section 2706: A Fairness Rule With a Fog Machine
Section 2706 says that a health plan or issuer shall not discriminate against a health care provider acting within the scope of that provider’s license or certification under state law. It also says plans are not required to contract with every willing provider and may use reimbursement differences based on quality or performance measures.
That sounds like a narrow provider access rule, not a command to cover every CAM service. Federal guidance has generally treated it as self-implementing and allowed plans to use good-faith interpretations, reasonable medical management, network rules, and covered-benefit limitations. In plain English: if a service is not covered, Section 2706 does not magically turn it into a covered benefit while wearing a cape.
Still, the ambiguity matters. CAM advocates have often treated the provision as a doorway to insurance parity. If a plan covers back pain evaluation by one licensed provider, should it also cover spinal manipulation from a chiropractor? If it covers pain management, should it cover acupuncture? If a state licenses naturopaths, should a plan reimburse naturopathic services that overlap with primary care, nutrition counseling, or chronic disease management?
The policy risk is that “do not discriminate by license” becomes “pay for my profession’s services,” even when evidence, training standards, scope of practice, and clinical outcomes differ substantially. That is not nondiscrimination. That is benefit expansion through statutory fog.
Why Licensure Is Not the Same as Evidence
State licensure proves that a state has created a legal category. It does not prove that every service within that category is effective, necessary, cost-effective, or appropriate for insurance coverage. States license many occupations. Licensure can protect consumers from fraud and incompetence, but it is not a scientific gold medal.
This distinction is essential. A treatment should earn broad insurance coverage because it helps patients in measurable ways, compares reasonably with alternatives, has acceptable risks, and makes sense economically. “My profession is licensed” is not enough. A driver’s license means you may operate a car. It does not mean NASCAR owes you a contract.
Conventional medicine is far from perfect. Plenty of mainstream procedures have later been questioned, narrowed, or abandoned after better evidence arrived. That is precisely the point: coverage decisions should move toward stricter evidence review, not away from it. If medicine has a problem with low-value care, the solution is not to add more low-value care wearing hemp sandals.
CAM Coverage Can Undermine the ACA in Four Big Ways
1. It Can Raise Costs Without Improving Outcomes
Supporters of CAM coverage often argue that alternative approaches may reduce expensive drug use, imaging, specialist visits, or surgery. Sometimes that hypothesis deserves study. For example, non-drug approaches for low back pain, including exercise, spinal manipulation, acupuncture, yoga, and massage, have appeared in clinical discussions because back pain is common, frustrating, and frequently overtreated with medications and imaging.
But “may reduce costs” is not the same as “does reduce costs across an insured population.” If CAM services are added on top of conventional care instead of replacing ineffective or risky care, utilization rises. A patient may still get the office visit, MRI, prescription, and specialist referral, then add acupuncture because insurance now helps pay for it. Congratulations: the system has achieved integration by making the bill longer.
2. It Weakens Evidence-Based Benefit Design
The ACA already forces insurers to cover many essential categories. That makes sense when the benefits are tied to recognized medical needs. But when coverage decisions are influenced by provider nondiscrimination arguments, the evidence threshold can shift from “Does this work?” to “Is this provider licensed to do it?”
That shift is dangerous. Health plans should be allowed to ask hard questions: Is the service medically necessary? Does it outperform placebo or usual care? Is it safe? Is it cost-effective? Is it recommended by credible clinical guidelines for this condition? Is the claim biologically plausible, or does it require us to believe that invisible energy fields forgot to bring documentation?
3. It Creates Inconsistent Coverage Across States
Because professional scope of practice is largely governed by state law, CAM coverage pressure can vary wildly by geography. One state may license naturopaths broadly. Another may not. One state may define acupuncture practice narrowly. Another may allow wider claims. If federal insurance rules lean too heavily on state licensure, national health policy becomes a patchwork quilt sewn by lobbyists.
The ACA was supposed to create a more reliable baseline of coverage. A patient buying marketplace coverage should not need a law degree, a medical degree, and a spirit guide to understand whether a service is covered.
4. It Distracts From the ACA’s Hardest Problems
The ACA still struggles with affordability, narrow networks, insurer participation, deductibles, subsidy cliffs, rural access, and the high price of hospital care, specialty drugs, and chronic disease management. These are not small issues. They are the main event.
Forcing or pressuring insurers to cover more CAM services does little to solve those structural problems. It may even make them harder by adding benefit mandates while policymakers are trying to keep premiums manageable. That is like noticing your boat is leaking and deciding the urgent priority is a nicer cupholder.
The Best Argument for CAM Coverage
To be fair, CAM supporters are not always making silly arguments. Some patients report meaningful relief from acupuncture, massage, yoga, mindfulness, or spinal manipulation. Some conventional options for chronic pain are disappointing, risky, or expensive. The opioid crisis made many clinicians more open to non-drug pain strategies, and that openness is reasonable.
There is also a fairness argument. If a plan covers a service when delivered by one type of clinician, why exclude another licensed clinician who can safely provide a similar service within scope? For example, if a patient needs conservative management for uncomplicated low back pain, it may be reasonable for a plan to include certain non-drug options when supported by evidence and proper safeguards.
That is the strongest version of the pro-CAM case: coverage should follow evidence, patient safety, and value, not professional turf. The problem is that this argument works only when CAM advocates accept the same evidence standards they demand from everyone else. Pick one rulebook. Do not bring science to the hearing and astrology to the marketing brochure.
A Smarter Policy Approach
The solution is not to ban all CAM coverage. That would be overly blunt. Some complementary approaches may be appropriate for certain conditions, especially when used as adjuncts rather than replacements. The better solution is to make coverage evidence-based, condition-specific, and outcome-aware.
Insurers should be able to cover acupuncture for specific pain conditions if evidence and guidelines support it, while refusing to cover acupuncture for unrelated claims that have not been shown to work. Plans might cover supervised exercise therapy, cognitive behavioral therapy for chronic pain, or limited spinal manipulation for certain musculoskeletal problems, while excluding homeopathy, detox regimens, energy healing, or broad naturopathic “immune boosting” packages.
Coverage should depend on the service, condition, evidence, and clinical contextnot merely the provider’s license. That protects patients, preserves flexibility, and keeps the ACA focused on care that actually improves health.
What “Harkin’s Folly” Teaches Us
“Harkin’s folly” is not just a jab at one senator or one provision. It is a warning about how good intentions can produce messy policy when evidence becomes secondary to access rhetoric. The ACA was already a delicate compromise. Adding ambiguous language that CAM groups could interpret as a path to parity created needless conflict inside a law that had enough enemies without inviting homeopathy to the budget meeting.
Health reform needs compassion, but compassion without evidence can become expensive theater. Patients deserve coverage for care that is safe, effective, and financially responsible. They also deserve honesty. If a therapy is relaxing, say it is relaxing. If it may help a narrow condition modestly, say that. If it claims to cure cancer, reverse diabetes, realign invisible energy, or detoxify the spleen’s emotional Wi-Fi, maybe do not send the bill to everyone’s insurance pool.
Real-World Examples: Where the Line Gets Blurry
Low back pain is the classic example because it sits at the intersection of conventional medicine’s limitations and CAM’s opportunity. Many patients with back pain do not need surgery. Many do not benefit from aggressive imaging. Some improve with time, movement, reassurance, physical therapy, or non-drug interventions. In that context, limited coverage of acupuncture, massage, or spinal manipulation may be defensible when tied to evidence-based guidelines and visit limits.
But the same logic should not be stretched into a blank check. If a chiropractor claims spinal adjustments treat asthma, ear infections, immune weakness, or infant colic, coverage should stop at the evidence border. If a naturopath orders extensive supplement protocols for vague “toxicity,” insurers should not be forced to pay because the provider has a license. If an acupuncturist treats chemotherapy nausea as an adjunct, that is a very different claim from treating cancer itself.
The public policy challenge is to separate reasonable adjunctive care from medical cosplay. The former may have a place. The latter should remain a private purchase, like scented candles, premium yoga pants, and that one blender people buy because it sounds like a jet engine with a retirement plan.
Why This Matters for Patients
Patients often see coverage as validation. If insurance pays for a treatment, many people assume it must work. That assumption is understandable but risky. Insurance covers plenty of things for reasons other than strong evidence: negotiated contracts, state mandates, employer preferences, legacy benefits, or political pressure.
When CAM services enter coverage through nondiscrimination pressure rather than evidence review, patients may be misled. They may spend time and money on services that provide little benefit. Worse, they may delay effective treatment. That is especially dangerous for cancer, heart disease, infections, autoimmune disease, diabetes, and serious mental health conditions.
A patient-centered ACA should protect access and protect patients from low-value care. Those goals are not enemies. In fact, they are twins who occasionally argue over the thermostat.
Experience-Based Reflections: What This Debate Looks Like on the Ground
Anyone who has watched patients navigate American health insurance knows the system already feels like a maze designed by a committee that hated both patients and maps. People struggle to understand deductibles, formularies, prior authorization, network tiers, referral rules, and surprise bills. Into that confusion, CAM coverage adds another layer: What counts as covered care? Which provider type is eligible? How many visits are allowed? Is the service medically necessary, wellness-oriented, or simply nice to have?
In everyday conversations, patients rarely talk like policy analysts. They say things such as, “My friend’s plan covered acupuncture, why won’t mine?” or “My chiropractor says the ACA requires coverage.” Sometimes the insurer’s answer is clear. Sometimes it is buried in plan documents written in the ancient dialect of Corporate Fog. That confusion creates frustration and distrust, even when the plan is following a reasonable interpretation of the law.
Clinicians face a related problem. Primary care doctors may support certain non-drug approaches for pain, stress, or mobility, but they also worry about patients being pulled into unsupported claims. A physician might be comfortable with a patient trying yoga for chronic back pain, but not comfortable with a naturopath telling that same patient to stop blood pressure medication in favor of supplements. Both may be marketed under the broad umbrella of “natural health,” but clinically they live on different planets.
Insurers, meanwhile, are not beloved institutions. When they deny coverage, people often assume greed is the only reason. Sometimes that assumption is fair; insurers have earned plenty of side-eye. But not every denial is villainy. A plan that refuses to cover unproven treatments is doing part of what insurance should do: preserve pooled dollars for care with demonstrated value. The trick is making that process transparent, consistent, and evidence-based, rather than arbitrary.
The best patient experience would not be a world where every CAM claim is covered. It would be a world where patients can see a simple explanation: this therapy is covered for these conditions because evidence supports it; this one is not covered because evidence is weak; this one is excluded because it is unsafe or implausible; this one is available only after standard conservative treatment. That kind of clarity would reduce confusion and make coverage feel less like a roulette wheel wearing a headset.
There is also a cultural lesson. Many patients turn to CAM because conventional medicine can feel rushed, impersonal, and obsessed with billing codes. A 50-minute CAM visit may feel more healing than a 12-minute office appointment, even if the clinical theory behind the CAM treatment is shaky. Conventional medicine should take that seriously. Time, listening, touch, reassurance, lifestyle support, and shared decision-making matter. But the answer is to make evidence-based care more humane, not to reimburse every comforting ritual as medicine.
In that sense, “Harkin’s folly” is not only about CAM. It is about the temptation to solve dissatisfaction with symbolism. Patients want care that listens. CAM providers offer listening. Policymakers respond by expanding access. But if the covered service lacks evidence, the system has treated the vibe rather than the disease. That may feel good temporarily, but it does not build a stronger ACA.
A mature health system can hold two thoughts at once: patients deserve respectful choices, and public insurance dollars should follow evidence. The ACA’s future depends on that balance. Coverage should be generous where science is strong, cautious where evidence is uncertain, and skeptical where claims float away from reality like a balloon at a child’s birthday party.
Conclusion
The debate over Harkin’s folly and CAM coverage is really a debate over what health insurance is for. If insurance is meant to cover whatever a licensed provider can legally offer, premiums will rise and evidence standards will weaken. If insurance is meant to cover care that improves health, protects patients, and uses pooled dollars responsibly, then CAM must meet the same test as everything else.
The ACA does not need more ambiguity. It needs clearer standards, better affordability, stronger networks, and benefit design rooted in evidence rather than professional pressure. Complementary therapies may have a limited role when they are safe, effective, and condition-specific. But forcing insurers to cover CAM broadly would undermine the ACA’s central promise: meaningful health coverage that people can actually afford.
In health policy, good intentions are not enough. The question is not whether a therapy is popular, natural, licensed, or wrapped in soothing music. The question is whether it works, for whom, under what conditions, at what cost, and compared with what alternative. That is the standard the ACA should defend. Anything less is not reform. It is just a more expensive waiting room with better incense.
